Literature DB >> 12117691

Relapse of rheumatoid arthritis after substitution of oral for parenteral administration of methotrexate.

A Rozin, D Schapira, A Balbir-Gurman, Y Braun-Moscovici, D Markovits, D Militianu, M A Nahir.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12117691      PMCID： PMC1754195          DOI： 10.1136/ard.61.8.756

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  8 in total

1.  [Methotrexate: advantages of subcutaneous administration].

Authors:  K Krüger
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

Review 2.  British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.

Authors:  Christopher Andrew Lamb; Nicholas A Kennedy; Tim Raine; Philip Anthony Hendy; Philip J Smith; Jimmy K Limdi; Bu'Hussain Hayee; Miranda C E Lomer; Gareth C Parkes; Christian Selinger; Kevin J Barrett; R Justin Davies; Cathy Bennett; Stuart Gittens; Malcolm G Dunlop; Omar Faiz; Aileen Fraser; Vikki Garrick; Paul D Johnston; Miles Parkes; Jeremy Sanderson; Helen Terry; Daniel R Gaya; Tariq H Iqbal; Stuart A Taylor; Melissa Smith; Matthew Brookes; Richard Hansen; A Barney Hawthorne
Journal:  Gut       Date:  2019-09-27       Impact factor: 23.059

3.  Methotrexate: optimizing the efficacy in rheumatoid arthritis.

Authors:  Jürgen Braun
Journal:  Ther Adv Musculoskelet Dis       Date:  2011-06       Impact factor: 5.346

Review 4.  Outcomes related to methotrexate dose and route of administration in patients with rheumatoid arthritis: a systematic literature review.

Authors:  Susan M Goodman; Bruce N Cronstein; Vivian P Bykerk
Journal:  Clin Exp Rheumatol       Date:  2014-12-23       Impact factor: 4.473

5.  Better efficacy of methotrexate given by intramuscular injection than orally in patients with rheumatoid arthritis.

Authors:  J Wegrzyn; P Adeleine; P Miossec
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 6.  Optimal dosage and route of administration of methotrexate in rheumatoid arthritis: a systematic review of the literature.

Authors:  K Visser; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2008-11-25       Impact factor: 19.103

7.  Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  K Visser; W Katchamart; E Loza; J A Martinez-Lopez; C Salliot; J Trudeau; C Bombardier; L Carmona; D van der Heijde; J W J Bijlsma; D T Boumpas; H Canhao; C J Edwards; V Hamuryudan; T K Kvien; B F Leeb; E M Martín-Mola; H Mielants; U Müller-Ladner; G Murphy; M Østergaard; I A Pereira; C Ramos-Remus; G Valentini; J Zochling; M Dougados
Journal:  Ann Rheum Dis       Date:  2008-11-25       Impact factor: 19.103

Review 8.  Update on subcutaneous methotrexate for inflammatory arthritis and psoriasis.

Authors:  Gino Antonio Vena; Nicoletta Cassano; Florenzo Iannone
Journal:  Ther Clin Risk Manag       Date:  2018-01-09       Impact factor: 2.423
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.